Skip to content
  • 6,719 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice

Notice of Intent to Sole Source: Canine Oxygen Carrier Manufacturing Restoration and Regulatory Activities

HT942525C0035

Defense Health Agency (Dha), Army Med Res Acq Activity. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

127 open like this View on SAM.gov Markdown

Awarded

Hemoglobin Oxygen Therapeutics LLC

$12,534,579.00 on the award notice, May 22, 2025, contract HT942525C0035

Get the next one like this from Defense Health Agency (Dha) by email, the day it is posted.Find my opportunities

This one was awarded in 2025

127 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

All 127 open in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

Description

As published on SAM.gov.

This requirement is intended to 1) restore manufacturing operations and processes and 2) obtain regulatory approval of Oxyglobin®, a canine oxygen carrier for use in damage control resuscitation of military working dogs. Anticipated activities may include (but are not limited to) manufacturing process optimization and implementation; manufacturing process validation; and regulatory strategy and development.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Hemoglobin Oxygen Therapeutics LLC
UEI
UJAMF5FC81N9
CAGE
7NSG9
Vendor location
Souderton, PA
Contract
HT942525C0035, definitive contract
Obligated
$9,559,947.80, current value $12,534,579
Actions
6 between May 22, 2025 and March 16, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Canine Oxygen Carrier Manufacturing Restoration and Regulatory Activities
Match
award number HT942525C0035 equals the contract number; same awarding office HT9425 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 28, 2025

    Award notice, originally special notice

    Awarded to HEMOGLOBIN OXYGEN THERAPEUTICS LLC Souderton for $12,534,579. SAM.gov, notice c3e9464c192a48abbe7c7dbeb2976057

Points of contact